vs
LifeStance Health Group, Inc.（LFST）与Progyny, Inc.（PGNY）财务数据对比。点击上方公司名可切换其他公司
LifeStance Health Group, Inc.的季度营收约是Progyny, Inc.的1.2倍（$382.2M vs $318.4M），Progyny, Inc.净利率更高（3.9% vs 3.1%，领先0.9%），LifeStance Health Group, Inc.同比增速更快（17.4% vs 6.7%），Progyny, Inc.自由现金流更多（$48.6M vs $46.6M），过去两年LifeStance Health Group, Inc.的营收复合增速更高（12.8% vs 7.0%）
LifeStance Health Group是美国的门诊行为健康服务提供商，支持线下面诊与远程诊疗两种服务模式，业务涵盖心理咨询、精神科诊疗、经颅磁刺激（TMS）以及氯胺酮治疗等。该公司曾多次因劳动违规、客户信息泄露及误导投资者相关问题遭遇诉讼。
Progyny, Inc.是总部位于美国的领先生育与家庭构建福利服务商，主要与企业雇主合作，提供试管婴儿、生育力保存、收养协助、代孕支持等综合生育相关福利方案，覆盖多个行业的雇员群体。
LFST vs PGNY — 直观对比
营收规模更大
LFST
是对方的1.2倍
$318.4M
营收增速更快
LFST
高出10.7%
6.7%
净利率更高
PGNY
高出0.9%
3.1%
自由现金流更多
PGNY
多$1.9M
$46.6M
两年增速更快
LFST
近两年复合增速
7.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $382.2M | $318.4M |
| 净利润 | $11.7M | $12.5M |
| 毛利率 | — | 24.1% |
| 营业利润率 | 4.7% | 4.8% |
| 净利率 | 3.1% | 3.9% |
| 营收同比 | 17.4% | 6.7% |
| 净利润同比 | 264.1% | 18.5% |
| 每股收益（稀释后） | — | $0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LFSTPGNY
| Q4 25 | $382.2M | $318.4M | ||
| Q3 25 | $363.8M | $313.3M | ||
| Q2 25 | $345.3M | $332.9M | ||
| Q1 25 | $333.0M | $324.0M | ||
| Q4 24 | $325.5M | $298.4M | ||
| Q3 24 | $312.7M | $286.6M | ||
| Q2 24 | $312.3M | $304.1M | ||
| Q1 24 | $300.4M | $278.1M |
净利润LFSTPGNY
| Q4 25 | $11.7M | $12.5M | ||
| Q3 25 | $1.1M | $13.9M | ||
| Q2 25 | $-3.8M | $17.1M | ||
| Q1 25 | $709.0K | $15.1M | ||
| Q4 24 | $-7.1M | $10.5M | ||
| Q3 24 | $-6.0M | $10.4M | ||
| Q2 24 | $-23.3M | $16.5M | ||
| Q1 24 | $-21.1M | $16.9M |
毛利率LFSTPGNY
| Q4 25 | — | 24.1% | ||
| Q3 25 | — | 23.2% | ||
| Q2 25 | — | 23.7% | ||
| Q1 25 | — | 23.4% | ||
| Q4 24 | — | 21.3% | ||
| Q3 24 | — | 20.7% | ||
| Q2 24 | — | 22.5% | ||
| Q1 24 | — | 22.4% |
营业利润率LFSTPGNY
| Q4 25 | 4.7% | 4.8% | ||
| Q3 25 | 2.0% | 6.9% | ||
| Q2 25 | -0.9% | 7.3% | ||
| Q1 25 | 0.5% | 7.5% | ||
| Q4 24 | 0.3% | 5.3% | ||
| Q3 24 | 0.0% | 4.3% | ||
| Q2 24 | -5.1% | 6.8% | ||
| Q1 24 | -5.6% | 6.7% |
净利率LFSTPGNY
| Q4 25 | 3.1% | 3.9% | ||
| Q3 25 | 0.3% | 4.4% | ||
| Q2 25 | -1.1% | 5.1% | ||
| Q1 25 | 0.2% | 4.6% | ||
| Q4 24 | -2.2% | 3.5% | ||
| Q3 24 | -1.9% | 3.6% | ||
| Q2 24 | -7.5% | 5.4% | ||
| Q1 24 | -7.0% | 6.1% |
每股收益（稀释后）LFSTPGNY
| Q4 25 | — | $0.14 | ||
| Q3 25 | — | $0.15 | ||
| Q2 25 | — | $0.19 | ||
| Q1 25 | — | $0.17 | ||
| Q4 24 | — | $0.12 | ||
| Q3 24 | — | $0.11 | ||
| Q2 24 | — | $0.17 | ||
| Q1 24 | — | $0.17 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $248.6M | $112.2M |
| 总债务越低越好 | $282.8M | — |
| 股东权益账面价值 | $1.5B | $516.0M |
| 总资产 | $2.2B | $742.4M |
| 负债/权益比越低杠杆越低 | 0.19× | — |
8季度趋势，按日历期对齐
现金及短期投资LFSTPGNY
| Q4 25 | $248.6M | $112.2M | ||
| Q3 25 | $203.9M | $134.0M | ||
| Q2 25 | $188.9M | $132.5M | ||
| Q1 25 | $134.3M | $109.2M | ||
| Q4 24 | $154.6M | $162.3M | ||
| Q3 24 | $102.6M | $91.5M | ||
| Q2 24 | $87.0M | $95.0M | ||
| Q1 24 | $49.5M | $115.0M |
总债务LFSTPGNY
| Q4 25 | $282.8M | — | ||
| Q3 25 | $284.6M | — | ||
| Q2 25 | $286.4M | — | ||
| Q1 25 | $288.2M | — | ||
| Q4 24 | $290.0M | — | ||
| Q3 24 | $287.3M | — | ||
| Q2 24 | $288.0M | — | ||
| Q1 24 | $288.8M | — |
股东权益LFSTPGNY
| Q4 25 | $1.5B | $516.0M | ||
| Q3 25 | $1.5B | $560.0M | ||
| Q2 25 | $1.5B | $515.0M | ||
| Q1 25 | $1.5B | $467.2M | ||
| Q4 24 | $1.4B | $422.1M | ||
| Q3 24 | $1.4B | $434.9M | ||
| Q2 24 | $1.4B | $456.2M | ||
| Q1 24 | $1.4B | $571.6M |
总资产LFSTPGNY
| Q4 25 | $2.2B | $742.4M | ||
| Q3 25 | $2.1B | $795.2M | ||
| Q2 25 | $2.1B | $761.0M | ||
| Q1 25 | $2.1B | $730.3M | ||
| Q4 24 | $2.1B | $607.1M | ||
| Q3 24 | $2.1B | $660.0M | ||
| Q2 24 | $2.1B | $698.6M | ||
| Q1 24 | $2.1B | $794.3M |
负债/权益比LFSTPGNY
| Q4 25 | 0.19× | — | ||
| Q3 25 | 0.19× | — | ||
| Q2 25 | 0.19× | — | ||
| Q1 25 | 0.20× | — | ||
| Q4 24 | 0.20× | — | ||
| Q3 24 | 0.20× | — | ||
| Q2 24 | 0.20× | — | ||
| Q1 24 | 0.20× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $57.6M | $54.2M |
| 自由现金流经营现金流 - 资本支出 | $46.6M | $48.6M |
| 自由现金流率自由现金流/营收 | 12.2% | 15.3% |
| 资本支出强度资本支出/营收 | 2.9% | 1.8% |
| 现金转化率经营现金流/净利润 | 4.93× | 4.34× |
| 过去12个月自由现金流最近4个季度 | $110.0M | $191.8M |
8季度趋势，按日历期对齐
经营现金流LFSTPGNY
| Q4 25 | $57.6M | $54.2M | ||
| Q3 25 | $27.3M | $50.7M | ||
| Q2 25 | $64.4M | $55.5M | ||
| Q1 25 | $-3.1M | $49.8M | ||
| Q4 24 | $62.3M | $52.2M | ||
| Q3 24 | $22.7M | $44.5M | ||
| Q2 24 | $44.1M | $56.7M | ||
| Q1 24 | $-21.8M | $25.7M |
自由现金流LFSTPGNY
| Q4 25 | $46.6M | $48.6M | ||
| Q3 25 | $17.0M | $46.0M | ||
| Q2 25 | $56.6M | $50.2M | ||
| Q1 25 | $-10.3M | $47.0M | ||
| Q4 24 | $56.0M | $50.3M | ||
| Q3 24 | $17.7M | $42.7M | ||
| Q2 24 | $39.0M | $55.8M | ||
| Q1 24 | $-26.9M | $24.9M |
自由现金流率LFSTPGNY
| Q4 25 | 12.2% | 15.3% | ||
| Q3 25 | 4.7% | 14.7% | ||
| Q2 25 | 16.4% | 15.1% | ||
| Q1 25 | -3.1% | 14.5% | ||
| Q4 24 | 17.2% | 16.8% | ||
| Q3 24 | 5.7% | 14.9% | ||
| Q2 24 | 12.5% | 18.4% | ||
| Q1 24 | -9.0% | 8.9% |
资本支出强度LFSTPGNY
| Q4 25 | 2.9% | 1.8% | ||
| Q3 25 | 2.8% | 1.5% | ||
| Q2 25 | 2.2% | 1.6% | ||
| Q1 25 | 2.2% | 0.9% | ||
| Q4 24 | 1.9% | 0.6% | ||
| Q3 24 | 1.6% | 0.6% | ||
| Q2 24 | 1.6% | 0.3% | ||
| Q1 24 | 1.7% | 0.3% |
现金转化率LFSTPGNY
| Q4 25 | 4.93× | 4.34× | ||
| Q3 25 | 25.34× | 3.65× | ||
| Q2 25 | — | 3.24× | ||
| Q1 25 | -4.36× | 3.31× | ||
| Q4 24 | — | 4.95× | ||
| Q3 24 | — | 4.27× | ||
| Q2 24 | — | 3.44× | ||
| Q1 24 | — | 1.52× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LFST
暂无分部数据
PGNY
| Fertility Benefit Services | $208.6M | 66% |
| Pharmacy Benefit Services | $109.8M | 34% |
